Trademark: 86898168
Word
ANIMALCELLTHERAPIES
Status Date
Tuesday, June 13, 2017
Registration Number
5224117
Registration Date
Tuesday, June 13, 2017
Filing Date
Thursday, February 4, 2016
Published for Opposition
Tuesday, August 16, 2016
5 Cells for medical or clinical use; Stem cells for medical or veterinary purposes; Pharmaceutical preparations for use in tissue engineered and cell based veterinary and medical therapies for use in the treatment of osteoarthritis, neurologic conditions, inflammatory conditions, immune- mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations manufactured or modified by genetic engineering in the form of stem cells for veterinary and medical purposes; Pharmaceutical and veterinary preparations, namely, gene therapy products in the form of stem cells for therapeutic medical use; Biochemical preparations namely, preparations for use in gene therapy for the treatment of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Orthobiologic preparations, namely, biologic preparations in the nature of stem cells to achieve symptomatic relief and cures from various orthopedic diseases
1 Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; cells for scientific, laboratory or medical research; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; stem cells for research or scientific research purposes
42 Medical and scientific research services in the field of animal stem cells for research, diagnostic, and clinical use; biopharmaceutical development, research and evaluation services of stem cell-based therapeutics for the treatment of disease, injuries and disorders; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics
The mark consists of the words "ANIMALCELLTHERAPIES", with a profile of a dog's head shown in three parts, above the "A" in "ANIMAL".
ANIMAL CELL THERAPIES
Color is not claimed as a feature of the mark.
"ANIMAL CELL THERAPIES"
Dec 12, 2023
Post Registration Action Mailed - Sec. 8 & 15
Nov 17, 2023
Case Assigned To Post Registration Paralegal
May 22, 2023
Teas Section 8 & 15 Received
Sep 5, 2022
Teas Change Of Correspondence Received
Sep 5, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 5, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 13, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jun 13, 2017
Registered-Principal Register
May 9, 2017
Notice Of Acceptance Of Statement Of Use E-Mailed
May 8, 2017
Allowed Principal Register - Sou Accepted
Apr 22, 2017
Notice Of Approval Of Extension Request E-Mailed
Apr 21, 2017
Statement Of Use Processing Complete
Apr 11, 2017
Use Amendment Filed
Apr 21, 2017
Sou Extension 1 Granted
Apr 11, 2017
Sou Extension 1 Filed
Apr 20, 2017
Case Assigned To Intent To Use Paralegal
Apr 11, 2017
Sou Teas Extension Received
Apr 11, 2017
Teas Statement Of Use Received
Oct 11, 2016
Noa E-Mailed - Sou Required From Applicant
Aug 16, 2016
Official Gazette Publication Confirmation E-Mailed
Aug 16, 2016
Published For Opposition
Jul 27, 2016
Notification Of Notice Of Publication E-Mailed
Jul 6, 2016
Approved For Pub - Principal Register
Jul 6, 2016
Examiner's Amendment Entered
Jul 6, 2016
Notification Of Examiners Amendment E-Mailed
Jul 6, 2016
Examiners Amendment E-Mailed
Jul 6, 2016
Examiners Amendment -Written
Jun 2, 2016
Notification Of Non-Final Action E-Mailed
Jun 2, 2016
Non-Final Action E-Mailed
Jun 2, 2016
Non-Final Action Written
May 19, 2016
Assigned To Examiner
Feb 11, 2016
Notice Of Design Search Code E-Mailed
Feb 10, 2016
New Application Office Supplied Data Entered
Feb 8, 2016
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
